Members of Congress are advocating for increased oversight and reform after Jean Jethro Alexandre, a Haitian national in Florida, was convicted of healthcare fraud involving over $58 million in false claims against Medicare, Medicaid, and private insurers. Prosecutors accused Alexandre and his co-conspirators of recruiting fake patients and providing financial kickbacks for fraudulent prescriptions, primarily for HIV and AIDS medications, written by nurse practitioners involved in the scheme. Alexandre allegedly profited from insurance reimbursements for these fake prescriptions.
The case has raised concerns about the 340B Drug Pricing Program, which is designed to help safety-net providers serve low-income patients. Lawmakers and industry groups have criticized the program for weak oversight that allows exploitation. Representative Diana Harshbarger noted that the program, while created to assist vulnerable patients, has become poorly supervised, leading to opportunities for fraud.
Alexandre reportedly used a nonprofit health clinic he co-owned to purchase drugs at discounted rates through the 340B program, filling prescriptions that were later deemed fraudulent. Prosecutors indicated that some drugs were destroyed after being dispensed to these fake patients. Representative Morgan Griffith emphasized the need for continued scrutiny of the 340B program to prevent such fraud.
Alexandre is set to serve nearly 10 years in prison and will be deported after his sentence. He is also required to pay approximately $14.3 million in restitution. The Trump administration has intensified fraud investigations across federal programs, including Medicaid and Medicare, as part of a broader effort to address waste and abuse in these systems.